Those who said they thought they were getting enough sleep at night were less likely to suffer from depression (OR
0.35, 95% CI 0.28 to 0.43) and to have suicidal thoughts (OR 0.71, 95% CI 0.61 to 0.84).
"Later parental-set bedtimes therefore appear to result in shorter sleep durations and a higher likelihood of not getting
enough sleep, which in turn are associated with depression and suicidal ideation," the researchers wrote.
Lack of sleep could lead to depression through a couple mechanisms, they said.
First, too little sleep might result in inappropriate modulation of the emotional brain responses to aversive stimuli, they
said.
Second, moodiness resulting from not getting enough sleep could interfere with teens' ability to cope with daily
stresses and impair interpersonal relationships, eventually leading to depression.
Lack of sleep could cause suicidal ideation by impairing judgment, concentration, and impulse control, they wrote.
"Behavioral interventions that involve educating adolescents and their parents about healthier sleep hygiene practices
and helping them modify maladaptive sleep habits could serve as primary preventive measures against depression
and suicidal ideation," the researchers concluded.
They listed some limitations of the study:
• Parent-set bedtimes could be influenced by characteristics and behaviors of the child.
• The cross-sectional nature of the analysis limits the ability to determine temporal relationships between
bedtimes, sleep duration, and depression.
• The data set did not include information on school start times.
• Sleep duration was self-reported.
The study was supported by a grant from the Robert Wood Johnson Health and Society Scholars Program at
Columbia University. It used data from Add Health, a program project funded by a grant from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development with cooperative funding from 17 other agencies.
Gangwisch reported no conflicts of interest. One of his co-authors reported receiving research support from Actelion,
Ancile Pharmaceuticals, Arena, Aventis, Cephalon, Elan, Epix, Evotec, Forest, GlaxoSmithKline, H. lundbeck A/S,
King Pharmaceuticals, Merck, Neurim, Neurocrine Biosciences, Neurogen, Organon, Orphan Medical, Pfizer,
Respironics, sanofi-aventis, Sanofi-Synthelabo, Schering-Plough, Sepracor, Somaxon, Takeda, Targacept,
Transcept, UCB Pharma, Predix, Vanda, and Wyeth-Ayerst Research; serving as a consultant for Actelion, Alexza,
Arena, Aventis, Biovail, Boehringer Ingelheim, Cephalon, Elan, Eli Lilly, Evotec, Forest, GlaxoSmithKline, Jazz, King
Pharmaceuticals, Ligand, McNeil, Merck, Neurocrine Biosciences, Organon, Pfizer, Renovis, sanofi-aventis, Select
Comfort, Sepracor, Shire, Somnus, Takeda, Vela, and Wyeth-Ayerst Research; participating in speaking
engagements for Neurocrine Biosciences, King Pharmaceuticals, McNeil, sanofi-aventis, Sanofi-Synthelabo,
Sepracor, Takeda, Vela, and Wyeth-Ayerst Research; and having ownership in and serving as a director of Clinilabs
IPA and Clinilabs Physicians Services.
Primary source: Sleep
Source reference:
Gangwisch J, et al "Earlier parental set bedtimes as a protective factor against depression and suicidal ideation" Sleep 2010; 33:
97-106.